Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Der Urologe. Ausg. A
|
January 20, 2012
[Bone metastasis in prostate cancer]
F Moltzahn, G N Thalmann
Der Urologe. Ausg. A
|
March 9, 2012
[Lymphadenectomy for bladder cancer: current status and controversies]
T Metzger, G N Thalmann, P Zehnder
Der Urologe. Ausg. A
|
January 17, 2019
[Instillation therapies for urothelial carcinoma of the upper urinary tract]
P Bosshard, G N Thalmann, B Roth
Der Urologe. Ausg. A
|
April 14, 2017
[Therapeutic management of blunt testicular trauma]
B Lyttwin, F Moltzahn, G N Thalmann
Therapeutische Umschau. Revue Therapeutique
|
March 7, 2006
[Radical prostatectomy in the treatment of organ confined prostate cancer]
M Schumacher, G N Thalmann, U E Studer
Therapeutische Umschau. Revue Therapeutique
|
March 7, 2006
[Old and new interventional therapies in the treatment of symptomatic benign prostate hyperplasia (BPH)]
R M Müller, G N Thalmann, U E Studer
Prostate Cancer and Prostatic Diseases
|
May 12, 2016
MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor
V Genitsch, I Zlobec, G N Thalmann, et al.
Swiss Medical Weekly
|
May 7, 2009
Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer
C A Rentsch, M G Cecchini, G N Thalmann
The Journal of Urology
|
September 25, 1997
Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression
G N Thalmann, B Dewald, M Baggiolini, et al.
Urological Research
|
January 1, 1997
Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer?
F C Burkhard, R Markwalder, G N Thalmann, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Der Urologe. Ausg. A
|
January 20, 2012
[Bone metastasis in prostate cancer]
F Moltzahn, G N Thalmann
Der Urologe. Ausg. A
|
March 9, 2012
[Lymphadenectomy for bladder cancer: current status and controversies]
T Metzger, G N Thalmann, P Zehnder
Der Urologe. Ausg. A
|
January 17, 2019
[Instillation therapies for urothelial carcinoma of the upper urinary tract]
P Bosshard, G N Thalmann, B Roth
Der Urologe. Ausg. A
|
April 14, 2017
[Therapeutic management of blunt testicular trauma]
B Lyttwin, F Moltzahn, G N Thalmann
Therapeutische Umschau. Revue Therapeutique
|
March 7, 2006
[Radical prostatectomy in the treatment of organ confined prostate cancer]
M Schumacher, G N Thalmann, U E Studer
Therapeutische Umschau. Revue Therapeutique
|
March 7, 2006
[Old and new interventional therapies in the treatment of symptomatic benign prostate hyperplasia (BPH)]
R M Müller, G N Thalmann, U E Studer
Prostate Cancer and Prostatic Diseases
|
May 12, 2016
MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor
V Genitsch, I Zlobec, G N Thalmann, et al.
Swiss Medical Weekly
|
May 7, 2009
Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer
C A Rentsch, M G Cecchini, G N Thalmann
The Journal of Urology
|
September 25, 1997
Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression
G N Thalmann, B Dewald, M Baggiolini, et al.
Urological Research
|
January 1, 1997
Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer?
F C Burkhard, R Markwalder, G N Thalmann, et al.
Page
of 5